You are visiting United States

If this is incorrect,

REGION

COUNTRY

INVESTOR PROFILE

Investment Letters

OUR INVESTMENT EXPERTS OFFER THEIR IN-DEPTH ANALYSIS OF COMGEST STRATEGIES

EUROPE EQUITIES: HEALTHCARE - AN EASY PILL TO SWALLOW?

Around the world, people are living longer. As societies age, the demand for healthcare services is likely to grow. That’s why we view European medical devices, pharmaceutical products and healthcare technology as promising long-term investment opportunities.

European SMID Caps: Small is Beautiful

Smaller companies have underperformed in recent years as large-cap companies have recorded outsized returns. Despite this trend, we believe that there are several examples of smaller companies in Europe that possess the right mix of quality characteristics and growth drivers to potentially deliver substantial returns over the long run. At Comgest, we aim to build our portfolios with quality companies with enduring competitive advantages, irrespective of their size or market capitalisation.

GLOBAL ex-US EQUITIES: TIME TO DIVERSIFY? GO INTERNATIONAL

Over the past decade, U.S. growth and equities have consistently outperformed their global counterparts. For investors in the U.S., seeking returns elsewhere has seemed rather pointless. However, as market trends shift, investors fixating solely on index performance or geography may be overlooking significant opportunities to diversify in quality growth companies outside the United States, writes our Global Equity team.

RIDING ESG WAVES ACROSS THE GLOBE: THE CASE OF THE US AND INDIA

At Comgest, we see the parallels between surfing and our own quality growth investment approach. Just as experienced surfers may wait hours before paddling out into the water and selecting a wave, we typically conduct years of fundamental research to determine whether a company meets our quality growth criteria. Liudmila Strakodonskaya, ESG Analyst, and Xing Xu, ESG Analyst / Portfolio Manager, detail how environmental, social and governance (ESG) factors fit into our research, investment selection and portfolio management process, spanning from India to the United States.

CHINA EQUITIES: IS CHINA STILL INVESTABLE?

China’s late September stimulus measures took many investors by surprise. Misperceptions and fears have convinced many that China is no longer an investable market. Beyond the macroeconomic challenges and headlines, Comgest believes that China remains a great hunting ground for quality growth companies.

HUMAN CAPITAL: THE UNDERESTIMATED RESOURCE IN COMPANY VALUATION

Financial metrics are crucial for evaluating a company’s value, but they don’t tell the whole story, writes ESG Analyst/Portfolio Manager Petra Daroczi. Human capital – the knowledge and skills people acquire throughout their lives – can be a significant competitive advantage, much like traditional capital expenditures on goods and services.

Comgest

IMPORTANT INFORMATION – PROFESSIONAL INVESTORS

This website may contain information on Comgest Strategies. This information is intended only for users who are US Accredited Investors and Qualified Purchasers and should not be transmitted or distributed without Comgest permission.

Please note that you must TICK the box below certifying that you are a US Accredited Investor and Qualified Purchaser before you can click [ACCEPT]:

I confirm that:

  • I am a U.S. Accredited Investor and Qualified Purchaser, as defined respectively in SEC Rule 501(a) under the U.S. Securities Act of 1933 and in Section 2(a)(51) of the U.S. Investment Company Act of 1940; and

 

or